These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3158917)

  • 1. [Recurrent calcium oxalate calculi in patients treated with piridoxylate].
    Daudon M; Reveilland RJ; Jungers P
    Presse Med; 1985 Apr; 14(15):846-7. PubMed ID: 3158917
    [No Abstract]   [Full Text] [Related]  

  • 2. [13 cases of drug-induced calculi].
    Teillac P; Daudon M; de Dreuzy O; Nguyen HV; Reveillaud RJ; Le Duc A
    Ann Urol (Paris); 1988; 22(4):278-81. PubMed ID: 2903714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piridoxilate-associated calcium oxalate urinary calculi: a new metabolic drug-induced nephrolithiasis.
    Daudon M; Reveillaud RJ; Jungers P
    Lancet; 1985 Jun; 1(8441):1338. PubMed ID: 2860529
    [No Abstract]   [Full Text] [Related]  

  • 4. Piridoxilate-associated nephrocalcinosis: a new form of chronic oxalate nephropathy.
    Vigeral P; Kenouch S; Chauveau D; Mougenot B; Méry JP
    Nephrol Dial Transplant; 1987; 2(4):275-8. PubMed ID: 3118272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Iatrogenic oxalic lithiasis caused by pyridoxilate].
    Wolf C; Maistre-Charransol G; Barthelemy C; Ottavioli JN; Thomas E; Thomas J
    Nephrologie; 1985; 6(5):225-7. PubMed ID: 4094636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium oxalate stones and hyperoxaluria secondary to treatment with pyridoxilate].
    Wolf C; Maistre-Charransol G; Barthélémy C; Thomas E; Thomas J; Arvis G; Steg A
    Ann Urol (Paris); 1985; 19(5):313-7. PubMed ID: 4083839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of the oxalate precursors on the experimental calcium oxalate urolithiasis].
    Morozumi M; Ogawa Y; Tanaka T; Yamaguchi K; Kitagawa R
    Nihon Hinyokika Gakkai Zasshi; 1987 Jun; 78(6):1025-31. PubMed ID: 3682493
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of pyridoxine supplementation on recurrent stone formers.
    Murthy MS; Farooqui S; Talwar HS; Thind SK; Nath R; Rajendran L; Bapna BC
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):434-7. PubMed ID: 7141762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-induced crystalluria: myths and realities].
    Daudon M; Réveillaud RJ
    Ann Biol Clin (Paris); 1986; 44(1):25-34. PubMed ID: 3486611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature.
    Khan SR; Hackett RL
    Scan Electron Microsc; 1985; (Pt 2):759-74. PubMed ID: 3901237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence of metabolic disorders in patients with recurrent urinary calculi].
    Schröder HE; Lohse R; Böhm WD
    Z Urol Nephrol; 1981 Mar; 74(3):235-41. PubMed ID: 7223105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug-induced urinary calculi in 1999].
    Daudon M
    Prog Urol; 1999 Dec; 9(6):1023-33. PubMed ID: 10658246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of calcium oxalate urolithiasis in experiment and its inhibition by pyridoxine and magnesium.
    Krídl J; Zvara V; Revúsová V; Ondrus B
    Czech Med; 1986; 9(3):124-9. PubMed ID: 3095070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of long-term pyridoxine administration on serum and urinary values of calculi-forming substances in Ca-oxalate urolithiasis].
    Revúsová V; Gratzlová J; Zvara V; Krídl J; Suchánek B
    Vnitr Lek; 1978 May; 24(5):445-50. PubMed ID: 96593
    [No Abstract]   [Full Text] [Related]  

  • 15. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic calcium oxalate urolithiasis and endogenous oxalate production.
    Baker PW; Rofe AM; Bais R
    Crit Rev Clin Lab Sci; 1996; 33(1):39-82. PubMed ID: 8833627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of magnesium oxide and vitamin B6 for the prevention of oxalate urolithiasis].
    Konstantinova OV; Chudnovskaia MV; Ianenko EK; Korolev VV
    Urol Nefrol (Mosk); 1987; (6):12-5. PubMed ID: 3438942
    [No Abstract]   [Full Text] [Related]  

  • 18. [Urinary calculi and indinavir sulfate in patients with HIV infection. Apropos of 4 cases].
    Chefchaouni MC; Thiounn N; Flam T; Zerbib M; Debré B
    J Urol (Paris); 1997; 103(1-2):35-6. PubMed ID: 9765778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifteen-year experience with Magurlit in the treatment of patients with uric acid calculi.
    Frang D
    Ther Hung; 1986; 34(1):26-34. PubMed ID: 3447298
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hydrochlorothiazide, allopurinol and magnesium oxide in the treatment of recurrent calcium urolithiasis].
    Musialik D; Głuszek J; Pieczyńska A
    Pol Tyg Lek; 1991 Oct 7-21; 46(40-42):739-42. PubMed ID: 1669148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.